Stefan Grass
Nessuna posizione attualmente
Profilo
Stefan Grass worked as a Medical Officer at CSL Behring AB.
He also served as the Chief Medical & Technology Officer at Bactiguard Holding AB from 2019 to 2020.
Dr. Grass obtained his graduate and doctorate degrees from Karolinska Institutet.
Precedenti posizioni note di Stefan Grass
| Società | Posizione | Fine |
|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Corporate Officer/Principal | - |
| BACTIGUARD HOLDING AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Stefan Grass
| Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Aziende private | 1 |
|---|---|
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Stefan Grass
